##semicolon##
интерстициальная пневмония; экспериментальная модель; биомаркеры; легочная ткань; воспаление; фиброз легких; цитокины; сурфактантные белки.##submission.citations##
Blasi F, Mantero M, PierAchille S, Tarsia P. Understanding the burden of pneumococcal disease in adults. Clin Microbiol Infect. 2012;18(Suppl.5):7-14. doi: 10.1111/j.1469-0691.2012. 03937.x;
Bonhomme O. André B., Gester F. et al. Biomarkers in systemic sclerosis-associated interstitial lung disease: review of the literature. Rheumatology (Oxford) 2019;58(9):1534–46. DOI: 10.1093/ rheumatology/kez230.
Christmann U, Buechner-Maxwell VA, Wi-tonsky SG, Hite RD. The role of pulmonary surfactant in respiratory diseases: Current knowledge in large animal health. J Vet Intern Med. 2009; 23:227-42. doi: 10.1111/j.1939-1676.2008. 0269.x
Distler O., Assassi S., Cottin V. et al. Predictors of progression in systemic sclerosis patients with interstitial lung disease. Maher Eur Respir J 20 20;55(5):1902026. DOI: 10.1183/13993003.020 26 2019 PMID: 32079645.
Elhai M., Hoffmann-Vold A.M., Avouac J. et al. Performance of candidate serum biomarkers for systemic sclerosis-interstitial lung disease. Arthritis Rheumatol 2019;71(6):972–82. DOI: 10.1002/art.40 815.
Guiot J., Moermans C., Henket M. et al. Blood biomarkers in idiopathic pulmonary fibrosis. Lung 2017;195(3):273–80. DOI: 10.1007/s00408-0 17-9993-5.
Hu Y., Wang L.S., Jin Y.P. et al. Serum Krebs von den Lungen-6 level as a diagnostic biomarker for interstitial lung disease in Chinese patients. Clin Respir J 2017;11(3):337–45. DOI: 10.1111/crj.12 341;
Ishikawa N., Hattori N., Yokoyama A. et al. Utility of KL-6/MUC1 in the clinical management of interstitial lung diseases. Respir Investig 2012;50 (1) :3–13.
Kinnula V.L., Ishikawa N., Bergmann U. et al. Proteomic approaches for studying human parenchymal lung diseases. Exp. Rev. Proteomics. 2009; l (6): 619–629.
Kohno N., Akiyama M., Kyoizumi S. et al. Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma. Jpn J Clin Oncol 1988;18(3):203–16. PMID: 3411786.
Kuroki Y., Takahashi H., Chiba H. et al. Surfactant proteins A and D: disease markers. Biochim Biophys Acta 1998;1408(2–3): 334–45. DOI: 10.10 16/s0925-4439(98)00079-9.
Modified IDSA/ATS minor criteria for severe community-acquired pneumonia best predicted mortality. Medicine (Baltimore). 2019;98(33):e169 14. doi: 10.1097/md.0000000000016914
Mulugeta S, Beers MF. The surfactant protein C: its unique properties and emerging immunomodulatory role in the lung. Microbes Infect. 2006; 8:2317-23. doi: 10.1016/j.micinf.2006.04.009.
Nagaoka T., Hasegawa M. et al. Elevated serum KL-6 levels in patients with systemic sclerosis: association with the severity of pulmonary fibrosis. Dermatology 2000;200(3):196–201. DOI: 10.1159/0 00018382.
Nihtyanova S.I., Sari A., Harvey J.C. et al. Using autoantibodies and cutaneous subset to develop outcome-based disease classification in systemic sclerosis. Arthritis Rheumatol 2020;72(3):465–76. DOI: 10.1002/art.41153.
Sosnovskaya A.V., Fomin V.V., Popova E.N. et al. Clinical value of surfactant protein D as a biomarker of pulmonary fibrosis in patients with scleroderma systematica in relation to the presence of gastroesophageal reflux. Ter Arck 2015;87(3):47. DOI: 10.17116/ terarkh201587342-47.
Sumida H., Asano Y., Tamaki Z. et al. Prediction of therapeutic response before and during i.v. cyclophosphamide pulse therapy for interstitial lung disease in systemic sclerosis: a longitudinal observational study. J Dermatol 2018;45(12):1425–33. DOI: 10.1111/1346-8138.14669.
Vieira F, Kung J, Bhatti F. Structure, genetics and function of the pul monary associated surfactant proteins A and D: The extra-pulmonary role of these C type lectins. Annals of Anatomy– Anatomischer Anzeiger. 2017; 211:184-201. doi: 10.1016/ j.aanat.2017.03.002
Курляндского (Каюмова Ю.Д., Таджи-ходжаева Ю.Х. Экспериментальная модель хро-нической обструктивной болезни лёгких с табакокурением в изучении мембранодеструктивных процессов // Вестник ассоциации пульмонологов центральной азии. 2020; выпуск 18 (№1-4), С.22-26.)